Acute Otitis Media Treatment Market
- 2026 年市場規模
- USD 3,360.5 Mn
- 2033 年預估規模
- USD 4,728.6 Mn
- 年複合成長率 CAGR
- 5%
以上數字由 Coherent Market Insights 於本報告中提出，量子訊息原樣引用。
授權報價
| Single User Price | $4,500 USD |
| Enterprise License | $10,000 USD |
完整報告名稱與涵蓋範圍
Acute Otitis Media Treatment Market, By Drug Type (Antibiotics, Nonsteroidal anti-Inflammatory drug, Analgesic, and Anaesthetic), By Formulation (Oral, and Topical), By End User (Hospitals, Retail pharmacies, and Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East and Africa)
報告摘要
Acute otitis media (AOM) is inflammation of the fluid in the middle ear. AOM is the most common infection and mainly caused in children under the age of 7 years. According to an article published American Family Physician Journal in 2013, around 80% of children will have at least one episode of acute otitis media (AOM) before their school age. AOM is mainly caused by bacteria such as Streptococcus pneumoniae (strep) and Hemophilus influenzae (H. flu) and viruses. Bacteria account for 85% cases of AOM and viruses account for only 15%. AOM is mostly treated with antibiotics usually for 7–10 days and with some analgesic and anesthetic in order to the reduce pain.
Market Dynamics
Increasing prevalence of acute otitis media is expected to be a major driver for growth of the market. Acute otitis media is a very common disease and occurs mostly in children, therefore, increasing prevalence of this disease is expected to increase demand for treatment drugs, thereby positively affecting market growth. According to an article published in The Journal of Laryngology & Otology, in 2013, prevalence of otitis media subtypes is between 7.1–12.8%. Furthermore, recent launches and FDA approvals for new drugs for the treatment of acute otitis media is also expected to drive the market growth in the near future. For instance, in 2015, Otonomy, Inc. received U.S. Food and Drug Administration (FDA) approval for its OTIPRIO (ciprofloxacin otic suspension) indicated for the treatment of pediatric patients with bilateral otitis media with effusion undergoing tympanostomy tube placement. In 2016, Otonomy, Inc. launched OTIPRIO in U.S. market.
Key features of the study
• This report provides in-depth analysis of acute otitis media treatment market and provides market size (USD Mn) and Cumulative Annual Growth Rate (CAGR %) for the forecast period (2026–2033), considering 2025 as the base year
• It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategy adopted by the leading players
• It profiles leading players in the global acute otitis media treatment market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies, and future plans
• Key companies covered as a part of this study include Pfizer, Inc., Eli Lilly and Company, Abbott Laboratories, GlaxoSmithKline plc., Bayer AG, Novartis AG, Pediapharm Inc., Sanofi S.A., and Bristol Myers Squibb Company.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launches, technology up-gradation, market expansion, and marketing tactics
• The global acute otitis media treatment market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
• Stakeholders would have ease in decision-making through the various strategy matrices used in analyzing the acute otitis media treatment market
Market Segmentation
• By Drug Type Insights (Revenue, USD Mn, 2021 - 2033)
o Antibiotics
o Nonsteroidal anti-Inflammatory drug
o Analgesic
o Anaesthetic
• By Formulation Insights (Revenue, USD Mn, 2021 - 2033)
o Oral
o Topical
• By Distribution Channel Insights (Revenue, USD Mn, 2021 - 2033)
o Hospitals
o Retail pharmacies
o Online pharmacies
• By Region Insights (Revenue, USD Mn, 2021 - 2033)
o North America
U.S.
Canada
o Latin America
Brazil
Argentina
Mexico
Rest of Latin America
o Europe
Germany
U.K.
Spain
France
Italy
Russia
Rest of Europe
o Asia Pacific
China
India
Japan
Australia
South Korea
ASEAN
Rest of Asia Pacific
o Middle East
GCC Countries
Israel
Rest of Middle East
o Africa
South Africa
North Africa
Central Africa
• Key Players
o Pfizer, Inc.
o Eli Lilly and Company
o Abbott Laboratories
o GlaxoSmithKline plc.
o Bayer AG
o Novartis AG
o Pediapharm Inc.
o Sanofi S.A.
o Bristol Myers Squibb Company
目錄 Table of Contents
Table of Contents
1. Research Objective and assumption
o Research Objectives
o Assumptions
o Abbreviations
2. Market Purview
o Report Description
Market Definition and Scope
o Executive Summary
Market Snippet, By Drug Type
Market Snippet, By Formulation
Market Snippet, By Distribution Channel
Market Snippet, By Region
o Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
o Market Dynamics
Drivers
Restraints
Market Opportunities
o Impact Analysis
o Technological Trends
o Unmet Needs
o Regulatory Scenario
o Recent Product Approvals/Launch
o Technological Advancement
o PEST Analysis
o Porter’s Five Forces Analysis
4. Global Acute Otitis Media Treatment Market, By Drug Type, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Antibiotics
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Nonsteroidal anti-Inflammatory drug
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Analgesic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Anaesthetic
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
5. Global Acute Otitis Media Treatment Market, By Formulation, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Oral
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Topical
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
6. Global Acute Otitis Media Treatment Market, By Distribution Channel, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, 2026 and 2033 (%)
Y-o-Y Growth Analysis, 2022–2033
Segment Trends
o Hospital
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Retail pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
o Online pharmacies
Introduction
Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (USD Mn)
7. Global Acute Otitis Media Treatment Market, By Region, 2021–2033 (USD Mn)
o Introduction
Market Share Analysis, By Region, 2026 and 2033 (%)
Y-o-Y Growth Analysis, For Regions, 2022–2033
o North America
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o U.S.
o Canada
o Europe
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o U.K.
o Germany
o Italy
o France
o Spain
o Russia
o Rest of Europe
o Asia Pacific
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o China
o India
o Japan
o ASEAN
o Australia
o South Korea
o Rest of APAC
o Latin America
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o Brazil
o Mexico
o Argentina
o Rest of Latin America
o Africa
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o Central Africa
o South Africa
o North Africa
o Middle East
Market Size and Forecast, By Drug Type, 2021–2033 (USD Mn)
Market Size and Forecast, By Formulation, 2021–2033 (USD Mn)
Market Size and Forecast, By Distribution Channel, 2021–2033 (USD Mn)
Market Size and Forecast, By Country, 2021–2033 (USD Mn)
o GCC
o Israel
o Rest of Middle East
8. Competitive Landscape
o Heat Map Analysis
o Company Profiles
Pfizer, Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Eli Lilly and Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Abbott Laboratories
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
GlaxoSmithKline plc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bayer AG
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Novartis AG
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Pediapharm Inc.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Sanofi S.A.
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
Bristol Myers Squibb Company
o Company Overview
o Product Portfolio
o Key Developments
o Financial Performance
o Strategies
9. Section
o References
o Research Methodology
o About us and Sales Contact
提及公司
同分類最新報告（醫療與生命科學）
常見問題
這份報告可以先索取樣本嗎？
可以。建議購買前先申請樣本，提出申請後約 2 個工作天內提供，您可以先確認內容涵蓋範圍是否符合需求。
報告價格如何計算？
報告以美元標價，台幣報價依當日匯率換算並加計 5% 營業稅。不同授權版本（單人／多人／企業全站）價格不同，量子訊息會評估您的使用情境後提供最優惠報價。
下單後多久交付？如何付款？
一般 3–7 個工作天交付，實際依出版商狀況於下單前確認。收到報告確認無誤後開立台幣發票，30 天內電匯付款即可。
量子訊息有限公司為 Coherent Market Insights 在台灣的授權代理，提供報告購買、樣本申請與授權諮詢。電話 +886 2 7751 5192 ・ 聯絡我們